Skip to content

Clinical trials

Completed Lymphoma, B-Cell, Marginal Zone trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Completed Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20111
20131
20141
20161
20171
20181
20192
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Gilead Sciences2
AstraZeneca1
BeiGene1
Cancer Research Campaign Clinical Trials Centre1
Epizyme, Inc.1
Incyte Corporation1
International Extranodal Lymphoma Study Group (IELSG)1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone18
Lymphoma, Follicular11
Lymphoma, Mantle-Cell9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Non-Hodgkin6
Lymphoma, B-Cell5
Waldenstrom Macroglobulinemia5
Burkitt Lymphoma4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.